Sonoma Pharmaceuticals Q2 EPS $(0.29) Misses $(0.24) Estimate, Sales $2.73M Miss $3.48M Estimate
Sonoma Pharmaceuticals Q2 EPS $(0.29) Misses $(0.24) Estimate, Sales $2.73M Miss $3.48M Estimate
索諾瑪製藥第二季度每股收益（0.29美元）未達到預期（0.24美元），銷售額273萬美元未達到348萬美元的預期
Sonoma Pharmaceuticals (NASDAQ:SNOA) reported quarterly losses of $(0.29) per share which missed the analyst consensus estimate of $(0.24) by 20.83 percent. This is a 12.12 percent increase over losses of $(0.33) per share from the same period last year. The company reported quarterly sales of $2.73 million which missed the analyst consensus estimate of $3.48 million by 21.52 percent. This is a 18.01 percent decrease over sales of $3.33 million the same period last year.
索諾瑪製藥公司（納斯達克股票代碼：SNOA）公佈季度每股虧損0.29美元，比分析師共識估計的0.24美元（0.24美元）低20.83％。這比去年同期每股虧損美元（0.33美元）增加了12.12％。該公司公佈的季度銷售額爲273萬美元，比分析師普遍估計的348萬美元低21.52％。這比去年同期的333萬美元銷售額下降了18.01％。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。